According to the Market Statsville Group (MSG), the Global pathogen reduction system Market was valued at USD 1,480.02 million in 2023 and is expected to grow from USD 1,781.94 million in 2024 to USD 5,426.28 million by 2033, by exhibiting a CAGR of 20.4% during the forecast period (2024-2033)
Pathogen reduction systems (PRS) are critical in various industries, especially in healthcare, food safety, and blood management, to ensure the safety and quality of products by reducing or eliminating harmful microorganisms. Pathogen reduction systems can be defined as the technologies or devices that can be widely applied to the market for reducing the contamination risk. Strict legal requirements and norms towards disinfection in different sectors, including food safety and blood transfusion, prompt high demand for pathogen reduction solutions. The increased rate of infections and new pathogens has led to a need for proper ways of controlling the pathogens. New developments in pathogen reduction technologies, which include increased efficiency in filtration processes and the development of additional chemical treatments, are opening up new market opportunities. More attention has been paid towards understanding the need to eliminate pathogens as a measure of enhancing product safety and quality in other industries.
Moreover, the seed capital and running costs of deploying state-of-the-art pathogen reduction technologies may be high for smaller firms. Integrating these pathogen reduction systems into a related process can be cumbersome and demands skills that lie in specialized niches. Difficulty in complying with divergent regulations and standards around the international arena is also likely to be a challenge for global players in this market. The use of nanomaterials in filtration systems is likely to raise the efficiency of pathogen removal. Two technologies called nanofiltration and ultrafiltration are also expected to grow in usage. They provide more precision and effectiveness in the elimination of pathogens. Probably, the most probable integration of multi-stage filtration will occur with membrane filtration in combination with UV or chemical treatment. Hybrid systems can ensure excellent control of pathogens without losing process efficiency.
Pathogen Reduction Systems (PRS): Technologies and processes that reduce the number of pathogens in biological and industrial products. These systems are used in transfusion safety, food and beverage processing, and pharmaceutical production.
Pathogen Reduction System Market Dynamics
The rising incidence of infectious diseases globally is one of the major drivers for the growth of the PRS market. Besides this, emergent and re-emergent pathogens threaten health systems in all sectors of the economy from healthcare to food and beverage processing, pharmaceuticals, and water treatment; therefore, there is a growing need to control pathogens effectively. The newly created concern over pathogen safety is consequently impacting demand and innovation in newer pathogen-reduction technologies. Increased mobility of individuals around the globe advances the spread of infectious diseases into other countries. Urbanization also increases the population near one another, allowing a more rapid spread of infection. Infectious diseases accounted for approximately 13% of global deaths as estimated by the WHO. In 2021, such infections caused about 7.7 million deaths, thus posing a big risk to communicable diseases.
Furthermore, The situation is aggravated by a rising incidence of antibiotic-resistant bacteria - sometimes dubbed superbugs - complicating treatment possibilities and increasing the imperative for effective pathogen control measures. Pathogen reduction systems are of prime importance in the management and mitigation of resistant organisms. An estimated 700,000 deaths occur every year worldwide due to antibiotic-resistant bacteria, reports the World Health Organization. Projections suggest that continued growth in resistance could result in 10 million deaths each year by the year 2050, rendering pathogen control a prominent area of concern. Global climate change is also affecting the habitats and behavior of disease-bearing organisms like mosquitoes and ticks, changing the spatial distribution in which vector-borne diseases are transmitted. Diseases can break out in new areas to where they have not been native.
There are several reasons why the introduction of pathogen reduction systems is considered a complex process. This complexity could have effects on healthcare, food and beverage processing, pharmaceuticals, as well as even water treatment sectors. Oncoming with new pathogen reduction systems may not be taken easily with other devices or equipment. It might conflict with the existing and require alterations or upgrades. Studies reveal that integrating the new pathogen reduction technologies with the current system might attract a charge as high as 10% to 20% of the total investment in new equipment. This points to amendment charges, upgrading, and some changes to be made in compatibility. There may be an amendment needed to the current process and what it entails to suit new pathogen reduction technologies. This will include changes in work procedures, staff training, and the modification of operating procedures among others.
Additionally, the integration stage may lead to downtime of some sectors' operations; this shutdown may range from hours to days. For instance, QUPAQ indicates that food processing operations that adopt new pathogen reduction systems may incur losses between $100,000 and $500,000 per day for loss in production depending on the scale of operation. It is difficult to select the appropriate pathogen reduction technology, as each application has its own needs. Each technology type has pros and cons, and operation mode is different for each one. Industry reports shown that about 30% of corporations experience severe problems when selecting the correct technology for pathogens. The main variables that cause these kinds of problems are the level of effectiveness, cost, and compatibility with existing processes.
The study categorizes the pathogen reduction system market based on technology, application, and end-user area at the regional and global levels.
Based on the application, pathogen reduction systems (PRS) have become vital in health services and blood transfusions. These systems ensure that the blood products and medical equipment are safe and of high quality because they eliminate or reduce harmful pathogens to an extent that could be lethal or cause reactions if introduced into patients' bodies. Pathogen reduction technologies are gaining more importance in the healthcare and blood transfusion sectors due to increasingly stringent safety measures and a critical need to ensure that infectious diseases do not get transmitted. According to the Director General of Health Services, the pathogen reduction systems for blood transfusion have captured the market size worth around $1.2 billion by 2023. It includes the systems being used in the treatment of blood products to ensure safety. The United States FDA and European Medicines Agency impose very strict standards upon blood safety.
Additionally, Compliance with such regulations also drives the adoption of advanced pathogen reduction systems. Such growth is spurred by advances in technology, increased demand for safe blood products, and infection control awareness. Pathogen reduction technologies, such as advances in filtration techniques, chemical treatments, and irradiation methods, are helping the blood safety protocols in being more effective and efficient. Some of the developments that have resulted in bringing about the much-needed changes include ultraviolet (UV) light use and newer chemicals agents, which have increased the pathogen inactivation rates and have helped in this market growth.
Based on the region, North America region itself creates a need for advanced pathogen reduction technologies for blood transfusion and health care settings in North America, with strict regulations and standards led by FDA and CDC. Large-scale research and development along with innovation are strong drivers for the growth of this market. For developers and commercialisers, North America presents a hotbed for the development and commercialization of pathogen reduction technology. Such factors as well-structured infrastructure in healthcare and the growing demand for safe blood products as well as various medical devices drive the market considerably. North America continues to witness increased applications with UV-C light, as well as improved filtration systems that find applications in water treatments and sterilization of medical products.
The pathogen reduction system market is a huge competitor and very competitive in the market. It uses methods such as partnerships, product launches, acquisitions, agreements, and expansion to increase its position in the market. Most divisions of firms concentrate on expanding their operations globally and establishing durable partnerships.
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Digital Pathology Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Dry Dental Vacuum Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 20243D Printed Nose Protection Masks Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Disposable Tissue Closure Clamp Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Light Cure Orthodontic Adhesive Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024